AU2001251370A1 - Antimicrobial methods and materials - Google Patents
Antimicrobial methods and materialsInfo
- Publication number
- AU2001251370A1 AU2001251370A1 AU2001251370A AU5137001A AU2001251370A1 AU 2001251370 A1 AU2001251370 A1 AU 2001251370A1 AU 2001251370 A AU2001251370 A AU 2001251370A AU 5137001 A AU5137001 A AU 5137001A AU 2001251370 A1 AU2001251370 A1 AU 2001251370A1
- Authority
- AU
- Australia
- Prior art keywords
- materials
- antimicrobial methods
- antimicrobial
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000000845 anti-microbial effect Effects 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56938—Staphylococcus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/305—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F)
- G01N2333/31—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26632700P | 2000-04-06 | 2000-04-06 | |
| US60/266,327 | 2000-04-06 | ||
| PCT/US2001/011177 WO2001077365A2 (en) | 2000-04-06 | 2001-04-06 | Antimicrobial methods and materials |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001251370A1 true AU2001251370A1 (en) | 2001-10-23 |
Family
ID=23014117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001251370A Abandoned AU2001251370A1 (en) | 2000-04-06 | 2001-04-06 | Antimicrobial methods and materials |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US6764823B2 (en) |
| EP (1) | EP1360315A2 (en) |
| AU (1) | AU2001251370A1 (en) |
| WO (1) | WO2001077365A2 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6764823B2 (en) | 2000-04-06 | 2004-07-20 | Pharmacia & Upjohn Company | Antimicrobial methods and materials |
| JP2005503831A (en) * | 2001-09-28 | 2005-02-10 | ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー | Antimicrobial methods and materials |
| EP1855717A4 (en) * | 2005-02-11 | 2009-12-23 | Ace Biosciences As | Surface-located streptococcus pneumoniae polypeptides |
| AU2008242250B2 (en) | 2007-04-19 | 2014-03-27 | Molecular Detection Inc. | Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria |
| US20110269138A1 (en) * | 2008-12-30 | 2011-11-03 | Qiagen Hamburg Gmbh | Method for detecting methicillin-resistant staphylococcus aureus (mrsa) strains |
| WO2020102507A1 (en) * | 2018-11-16 | 2020-05-22 | Azitra Inc | Auxotrophic strains of staphylococcus bacterium |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8205892D0 (en) | 1982-10-18 | 1982-10-18 | Bror Morein | IMMUNOGENT MEMBRANE PROTEIN COMPLEX, SET FOR PREPARATION AND USE THEREOF |
| US5587228A (en) | 1985-02-05 | 1996-12-24 | The Boeing Company | Microparticle enhanced fibrous ceramics |
| SE8405493D0 (en) | 1984-11-01 | 1984-11-01 | Bror Morein | IMMUNOGENT COMPLEX AND KITCHEN FOR PREPARING IT AND USING IT AS IMMUNOSTIMENTING AGENTS |
| US4877612A (en) | 1985-05-20 | 1989-10-31 | Frank M. Berger | Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process |
| ATE71303T1 (en) | 1986-01-14 | 1992-01-15 | Nederlanden Staat | PROCESS FOR THE PREPARATION OF IMMUNOLOGICAL COMPLEXES AND PHARMACEUTICAL COMPOSITION CONTAINING THEM. |
| US4806352A (en) | 1986-04-15 | 1989-02-21 | Ribi Immunochem Research Inc. | Immunological lipid emulsion adjuvant |
| CA1340522C (en) | 1987-03-10 | 1999-05-04 | Heinz Dobeli | Fusion proteins containing neighbouring histidines for improved purification |
| US5585277A (en) | 1993-06-21 | 1996-12-17 | Scriptgen Pharmaceuticals, Inc. | Screening method for identifying ligands for target proteins |
| AU3825995A (en) | 1994-10-04 | 1996-04-26 | New York University | Blocking expression of virulence factors in s. aureus |
| WO1999032657A1 (en) * | 1997-12-23 | 1999-07-01 | Microcide Pharmaceuticals, Inc. | Staphylococcus aureus histidine protein kinase essential genes |
| US6020121A (en) | 1995-09-29 | 2000-02-01 | Microcide Pharmaceuticals, Inc. | Inhibitors of regulatory pathways |
| US5783397A (en) | 1995-12-11 | 1998-07-21 | Northeastern University | Screening natural samples for new therapeutic compounds using capillary electrophoresis |
| US6737248B2 (en) * | 1996-01-05 | 2004-05-18 | Human Genome Sciences, Inc. | Staphylococcus aureus polynucleotides and sequences |
| JP2000509246A (en) * | 1996-02-20 | 2000-07-25 | スミスクライン・ビーチャム・コーポレイション | New compound |
| EP1002090A2 (en) * | 1997-05-06 | 2000-05-24 | Human Genome Sciences, Inc. | $i(ENTEROCOCCUS FAECALIS) POLYNUCLEOTIDES AND POLYPEPTIDES |
| US6455323B1 (en) | 1997-07-03 | 2002-09-24 | Pharmacia & Upjohn Company | Anti-bacterial methods and materials |
| US6111074A (en) | 1998-02-26 | 2000-08-29 | Smithkline Beecham Corporation | PyrH of Streptococcus pneumoniae |
| JP2002512777A (en) | 1998-04-27 | 2002-05-08 | スミスクライン・ビーチャム・コーポレイション | New pyrH |
| EP1109911A4 (en) | 1998-09-01 | 2005-04-27 | Human Genome Sciences Inc | Staphylococcus aureus genes and polypeptides |
| ES2353268T3 (en) | 1999-07-02 | 2011-02-28 | Morphosys Ag | GENERATION OF SPECIFIC UNION ELEMENTS THAT JOIN (POLI) PEPTIDES CODIFIED BY FRAGMENTS OF GENOMIC DNA OR EST. |
| CA2388734A1 (en) | 1999-09-01 | 2001-03-08 | Human Genome Sciences, Inc. | 37 staphylococcus aureus genes and polypeptides |
| AU1478301A (en) | 1999-11-09 | 2001-06-06 | Glaxo Group Limited | Staphylococcus epidermidis nucleic acids and proteins |
| EP1248813A2 (en) | 2000-01-04 | 2002-10-16 | Avi Biopharma, Inc. | Antisense antibacterial cell division composition and method |
| US6764823B2 (en) | 2000-04-06 | 2004-07-20 | Pharmacia & Upjohn Company | Antimicrobial methods and materials |
-
2001
- 2001-04-06 US US09/828,523 patent/US6764823B2/en not_active Expired - Fee Related
- 2001-04-06 EP EP01924745A patent/EP1360315A2/en not_active Withdrawn
- 2001-04-06 WO PCT/US2001/011177 patent/WO2001077365A2/en not_active Ceased
- 2001-04-06 AU AU2001251370A patent/AU2001251370A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001077365A2 (en) | 2001-10-18 |
| WO2001077365A3 (en) | 2003-08-21 |
| US6764823B2 (en) | 2004-07-20 |
| EP1360315A2 (en) | 2003-11-12 |
| US20020168697A1 (en) | 2002-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1621217B8 (en) | Antimicrobial powder and material | |
| AU2002235128A1 (en) | Expression miniarrays and uses thereof | |
| AU2001281758A1 (en) | Biocompatible materials | |
| AU2001287299A1 (en) | Benzoylpyrazols and their use as herbicides | |
| AU2001250875A1 (en) | Anti-microbial and immunostimulating composition | |
| AU2001280599A1 (en) | Compounds and methods | |
| AU2002243246A1 (en) | Cddo-compounds and combination therapies thereof | |
| AU2001253418A1 (en) | Compounds and methods | |
| AU2001277526A1 (en) | Substituted benzo-nitro-heterocycles and use thereof as herbicides | |
| AU2001240637A1 (en) | Novel imidazotriazinones and the use thereof | |
| AU2002219135A1 (en) | Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors | |
| AU2001264258A1 (en) | Nonwoven-fabric laminate and use thereof | |
| AU2002211717A1 (en) | Stresscopins and their uses | |
| AU2001239773A1 (en) | Baroplastic materials | |
| AU2001243394A1 (en) | Compounds and methods | |
| AU2001292936A1 (en) | Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines | |
| AU7458201A (en) | Laminate and use thereof | |
| AU2001295185A1 (en) | Multiplexing-interleaving and demultiplexing-deinterleaving | |
| AUPQ872300A0 (en) | Compounds and methods | |
| AU5464901A (en) | Dichloropyridyl- and dichloroisothiazolyl-thiocarboxamides and their use as microbicides | |
| AU2001278951A1 (en) | Compounds and methods | |
| AU2001237025A1 (en) | Antimicrobial composition and articles | |
| AU2000231564A1 (en) | Phosphororganic compounds and the use thereof | |
| AU2001251370A1 (en) | Antimicrobial methods and materials | |
| AU2001267589A1 (en) | Cycloalkyl - or cycloalkylmethyl-substituted 6-phenylphenanthridines |